Article
Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease
1 Aug 2016
Abstract excerpt
Alpha-1 antitrypsin (AAT) deficiency, characterized by low plasma levels of the serine protease inhibitor AAT, is associated with emphysema secondary to insufficient protection of the lung from neutrophil proteases. Although AAT augmentation therapy with purified AAT protein is efficacious, it requires weekly to monthly intravenous infusion of AAT purified from pooled human plasma, has the risk of viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
